Please assess the completion status of the following clinical trial:

Trial Title: Image Guided Therapy in the Treatment of Gliomas

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Histologically confirmed, newly diagnosed intracranial glioma~* A diagnostic contrast enhanced CT/MRI demonstrating the lesion prior to registration~* Karnofsky performance status \>= 60~* Ability to undergo MR imaging with the use of Gadolinium dye~* Patient must sign a study specific informed consent form; if the patient's mental status precludes his/her giving informed consent, written informed consent may be given by the patient's legal representative~Exclusion Criteria:~* Inability to obtain histological proof of glioma~* Allergy to Gadolinium contrast~* Any condition including metallic implants or cardiac pace makers that make the candidate ineligible for MR imaging~* Any medical condition including renal or cardiac insufficiency that make the candidate a high risk for gadolinium contrast administration~* Karnofsky performance status of =\< 50~* Prior history of radiation therapy to the brain~* Pregnancy

- Gender: ALL
- Minimum Age: 7 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Arm I (Type: EXPERIMENTAL): Patients undergo magnetic resonance spectroscopic imaging, functional magnetic resonance imaging (MRI), diffusion-weighted MRI, and perfusion-weighted MRI. Patients then undergo maximum surgical resection followed by intensity-modulated radiation therapy (IMRT) 5 days a week for 6 weeks.

Based on this trial design, predict the completion outcome and termination type (if applicable).